0
Your Cart
$ 0.00
:
Remove
No items found.
Product is not available in this quantity.
About
About
Staff & Leadership
Academy of Fellows
CBHD Membership
Research Library
Pellegrino Special Collection
Robert D. Orr Endowed Fellowship
Employment, Internship, &
Visiting Scholarship Opportunities
Contact
Resources
Issues & Topics
Case Studies
Book & Movie Reviews
Audio & Video
The Bioethics Podcast
CBHD Books & eBooks
Dignitas
Latest Volume
Editorial Board
Submission Guidelines
Archives
Annual Conference
2023 Annual Conference
Speakers
Schedule
Lodging
Everyday Bioethics
Intersections
DONATE
MEMBER LOG IN
SEARCH
DONATE
LOG OUT
User Account
Not a Member? Click Here
Newsletter
📬 New posts straight to your inbox
No spam ever. Read our
Privacy Policy
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tags
No items found.
Trending Now
No items found.
< Back To Current Dignitas Issue
COVID News Timeline (June-December 2022)
Heather Zeiger, MS, MA
View PDF
This Article Appears In:
Dignitas Vol. 29, No. 3-4 (Fall-Winter 2022)
Page(s):
26–28
Issues
No items found.
Tags:
No items found.
June 2022
June 1: “Omicron Is Outrunning the Vaccines Designed to Fight It” (
Axios
)
June 2: “COVID-Fatigued Health Worker Are Mobilizing” (
Axios
)
June 10: “Coronavirus Infection During Pregnancy Linked to Brain Development Problems in Babies” (
Los Angeles Times
)
June 14: “FDA Advisors Back Moderna’s COVID-19 Vaccine for Older Kids” (
Associated Press
)
June 14: “Pfizer’s Paxlovid Study Fails to Answer Key Questions Over Benefit for Broader Populations” (
STAT News
)
June 15: “FDA Advisory Panel Votes Unanimously That Pfizer and Moderna Shots Be Authorized for Young Children” (
STAT News
)
June 17: “FDA Authorizes 1
st
COVID-19 Shots for Infants, Preschoolers” (
Associated Press
)
June 17: “Omicron Poses About Half the Risk of Long COVID as Delta, New Research Finds” (
NPR
)
June 28: “FDA Advisors Recommend Updating COVID Booster Shots for Fall” (
Associated Press
)
June 28: “The Omicron Subvariants BA.4 and BA.5 Have Together Become Dominant in the U.S., the C.D.C. Estimates” (
The
New York Times
)
June 30: “Tweaked COVID Boosters in US Must Target New Omicron Types” (
Associated Press
)
July 2022
Jul 1: “COVID-19 Variant Boosters Won’t Need New Clinical Trials for Clearance, FDA Says” (
The Verge
)
Jul 6: “U.S. Maternal Deaths Spiked Upwards During Pandemic” (
U.S. News & World Report
)
Jul 7:“US Allows Pharmacists to Prescribe Pfizer’s COVID-19 Pill” (
Associated Press
)
Jul 7: “Doctors Are Clamoring for More Clarity on Paxlovid Prescribing Amid Covid-19 Rebound Concerns” (
STAT News
)
Jul 12: “Hopes of Covid-19 Reprieve Fade as BA.5 Subvariant Takes Over” (
The Wall Street Journal
)
Jul 14: “US Regulators OK New COVID-19 Shot Option from Novavax” (
Associated Press
)
Jul 21: “President Biden Tests Positive for Covid-19, But Has ‘Very Mild Symptoms’” (
STAT News
)
Jul 22: “The Pandemic Isn’t Over, But Most of U.S. States Formally Say That It’s No Longer a Health Emergency” (
The
New York Times
)
Jul 28: “China’s Wuhan Locks Down District with One Million People” (
The Wall Street Journal
)
August 2022
Aug 5: “Exclusive: Over 1 Million Courses of Paxlovid Prescribed in One Month for First Time” (
Axios
)
Aug 8: “Most Parents Are Saying No to Covid-19 Vaccines for Toddlers” (
The Wall Street Journal
)
Aug 12: “CDC Drops Quarantine, Distancing Recommendations for COVID” (
Associated Press
)
Aug 19: “U.S. Plans to Shift Bill for Covid Shots and Treatments to Insurers, Patients” (
The Wall Street Journal
)
Aug 22: “FDA Authorizes Novavax Vaccine for Ages 12 to 17” (
Axios
)
Aug 22: “Fauci to Step Down After Decades as Top US Infection Expert” (
Associated Press
)
Aug 26: “Moderna Sues Pfizer and BioNTech Over Covid-19 Vaccine” (
STAT News
)
Aug 30: “Millions in New COVID Lockdown as China Keeps Strict Policy” (
Associated Press
)
Aug 31: “US Clears Updated COVID Boosters Targeting Newest Variants” (
Associated Press
)
Aug 31: “WHO: New COVID Cases, Deaths Keep Falling Nearly Everywhere” (
Associated Press
)
September 2022
Sep 2: “FDA Authorizes Omicron-Targeted Booster Shots” (
MedPage Today
)
Sep 2: “’Game Changer’ Paxlovid Turns Into Pandemic Enigma” (
Axios
)
Sep 6: “Pfizer Isn’t Sharing Covid Vaccines with Researchers for Next-Gen Studies” (
STAT News
)
Sep 9: “Companies Are Dropping Vaccine Mandates” (
Axios
)
Sep 14: “WHO: COVID End ‘in Sight,’ Deaths at Lowest Since March 2020” (
Associated Press
)
Sep 15: “Donated COVID Drugs Start Flowing to Poor Nations—But Can’t Meet Demand” (
Nature
)
Sep 23: “Major Covid Holdouts in Asia Drop Border Restrictions” (
The
New York Times
)
Sep 26: “Pfizer Seeks to Expand Omicron Booster to 5-to-11-Year-Olds” (
Associated Press
)
Sep 27: “Canada Repeals Covid-19 Border Restrictions” (
The Wall Street Journal
)
Sep 30: “Sweden to Stop Offering Covid Jabs to Teenagers” (
Medical Xpress
)
Sep 30: “North Korea Launches Mass Covid-19 Vaccination Campaign” (
The Wall Street Journal
)
October 2022
Oct 5: “100,000 Coronavirus Genomes Reveal COVID’s Evolution in Africa” (
Nature
)
Oct 7: “Covid Defies China’s Lockdowns, Creating Chaos Ahead of Top Meeting” (
The New York Times
)
Oct 7: “From BQ.1.1 to XBB and Beyond: How the Splintering of Omicron Variants Could Shape Covid’s Next Phase” (
STAT News
)
Oct 7: “CDC Ends Daily Reporting of COVID Case and Death Data, in Shift to Weekly Updates” (
CBS News
)
Oct 13: “Europe Likely Entering Another COVID Wave, Says WHO and ECDC” (
Reuters
)
Oct 13: “FDA Authorizes Updated Covid-19 Boosters for Kids as Young as 5” (
STAT News
)
Oct 19: “Heart Risks, Data Gaps Fuel Debate Over COVID-19 Boosters for Young People” (
Science
)
Oct 19: “FDA Authorizes Booster Shot for Novavax’s Covid-19 Vaccine” (
STAT News
)
Oct 20: “Panel Votes to Add COVID Shots to Recommended Vaccinations” (
Associated Press
)
Oct 31: “COVID ‘Variant Soup’ Is Making Winter Surges Hard to Predict” (
Nature
)
November 2022
Nov 4: “When Covid-19, Flu and RSV Meet. The Potential for a Tripledemic.” (
The Wall Street Journal
)
Nov 7: “Study: Myocarditis Risk 2 to 3 Times Higher from Moderna Than Pfizer COVID-19 Vaccine” (
UPI
)
Nov 16: “’A Very Worrying Scenario’: Internal Documents on India Covid-19 Vaccination Raise Troubling Questions about Approval Process” (
STAT News
)
Nov 16: “Hospitalized or Not, COVID Symptoms Persist in Many After 2 Years” (
MedPage Today
)
Nov 17: “New COVID-19 Subvariants Replace BA.5 as Most Dominant in the U.S.” (
UPI
)
Nov 21: “Will Covid Boosters Prevent Another Wave? Scientists Aren’t so Sure.” (
The New York Times
)
Nov 22: “Real-World Data Show Updated Covid-19 Boosters Increase Protection Against Infection” (
STAT News
)
Nov 28: “China Protests Spread Over Government’s Covid Restrictions” (
The Wall Street Journal
)
Nov 29: “Covid Becomes Plague of Elderly, Reviving Debate Over ‘Acceptable Loss’” (
Washington Post
)
Nov 30: “Covid Evolution Wipes Out Another Antibody Treatment, Threatening the Country’s Medicine Cabinet” (
STAT News
)
December 2022
Dec 2: “Around 85% of Recent Covid Deaths Were among People Over 65. Why Have so Few Gotten Boosted?” (
NBC News
)
Dec 7: “China Eases Anti-COVID Measures Following Protests” (
Associated Press
)
Dec 8: “FDA Authorizes Updated Covid-19 Boosters for Youngest Children” (
STAT News
)
Dec 9: “Key Partner in Covax Will End Support for Middle-Income Nations” (
The New York Times
)
Dec 13: “Covid Vaccines Averted 3 Million Deaths in U.S., According to New Study” (
STAT News
)
Dec 15: “You Can Order Free COVID Tests again by Mail” (
NPR
)
Dec 21: “WHO ‘Very Concerned’ About Reports of Severe COVID in China” (
Associated Press
)
Dec 21: “Infectious Disease Board Recommends Hospitals Stop Screening Asymptomatic Patients for Covid-19” (
STAT News
)
Dec 30: “Medicare Keeps Spending More on COVID-19 Testing. Fraud and Overspending Are Partly Why.” (
ProPublica
)
Cite As:
Heather Zeiger, “COVID News Timeline (June-December 2022),”
Dignitas
29, no. 3–4 (2022): 26–28.